Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.65 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | TGM2 | P21980 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | APEX1 | P27695 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ACHE | P22303 | 3/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL31301132 | 0.98 | ZDHHC20 (0.62) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL20528844 | 0.98 | ZDHHC20 (0.62) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL31301131 | 0.98 | ZDHHC20 (0.62) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| Iodide SCHEMBL31301133 | 0.98 | ZDHHC20 (0.62) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| SCHEMBL18331491 | 0.98 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL3120286 | 0.96 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| Bromide SCHEMBL6116865 | 0.96 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| SCHEMBL192702 | 0.92 | ZDHHC20 (0.58) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| Iodide SCHEMBL17105877 | 0.91 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 | |
| Bromide SCHEMBL475865 | 0.91 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1014999-B1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GENZYME CORP (US) | 2004-12-08 | — | — | EP | claimed |
| EP-1014999-A1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 2000-07-05 | — | — | EP | claimed |
| EP-0915705-A1 | IONIC POLYMERS AS ANTI-INFECTIVE AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-05-19 | — | — | EP | claimed |
| WO-1999015186-A1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-04-01 | — | — | WO | claimed |
| WO-1997049413-A1 | IONIC POLYMERS AS ANTI-INFECTIVE AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1997-12-31 | — | — | WO | claimed |
| EP-3274069-B1 | METHOD OF PURIFYING A BIOLOGICAL COMPOSITION AND ARTICLE THEREFOR | 3M INNOVATIVE PROPERTIES CO (US) | 2020-08-19 | — | — | EP | disclosed |
| US-10562997-B2 | Method of purifying a biological composition and article therefor | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-02-18 | — | — | US | disclosed |
| US-20180066095-A1 | Method of Purifying a Biological Composition and Article Therefor | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2018-03-08 | — | — | US | disclosed |
| EP-3274069-A1 | METHOD OF PURIFYING A BIOLOGICAL COMPOSITION AND ARTICLE THEREFOR | 3M Innovative Properties Company (US) | 2018-01-31 | — | — | EP | disclosed |
| US-20160367980-A1 | ION-EXCHANGE POLYMER AND PRODUCTION METHOD THEREFOR, ELECTROLYTE MEMBRANE AND PRODUCTION METHOD THEREFOR, AND COMPOSITION FOR PRODUCING ION-EXCHANGE POLYMER | FUJIFILM CORPORATION (JP) | 2016-12-22 | — | — | US | disclosed |
| WO-2016153915-A1 | METHOD OF PURIFYING A BIOLOGICAL COMPOSITION AND ARTICLE THEREFOR | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-09-29 | — | — | WO | disclosed |
| EP-0915705-B1 | IONIC POLYMERS AS ANTI-INFECTIVE AGENTS | GENZYME CORP (US) | 2007-01-10 | — | — | EP | disclosed |
| US-20010053794-A1 | Ionic polymers as anti-infective agents | GENZYME CORPORATION | 2001-12-20 | — | — | US | disclosed |
| US-6290947-B1 | IN ONE EMBODIMENT, THE POLYMER IS A COPOLYMER COMPRISING A MONOMER HAVING A PENDANT AMMONIUM GROUP AND A HYDROPHOBIC MONOMER. | GELTEX PHARMACEUTICALS, INC. | 2001-09-18 | — | — | US | disclosed |
| EP-1014999-A1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 2000-07-05 | — | — | EP | disclosed |
| US-6034129-A | GASTROINTESTINAL DISORDERS | GELTEX PHARMACEUTICALS, INC. (US) | 2000-03-07 | — | — | US | disclosed |
| US-6007803-A | ADMINISTERING TO MAMMAL A CATIONIC POLYMER TO INHIBIT PATHOGENIC TOXINS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-12-28 | — | — | US | disclosed |
| EP-0915705-A1 | IONIC POLYMERS AS ANTI-INFECTIVE AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-05-19 | — | — | EP | disclosed |
| WO-1999015186-A1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-04-01 | — | — | WO | disclosed |
| WO-1997049413-A1 | IONIC POLYMERS AS ANTI-INFECTIVE AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1997-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010053794-A1 | Ionic polymers as anti-infective agents | PAM, ARG1, PIGS | ZDHHC20 2918/4885ZDHHC2 3988/4885TSHR 4262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.